`
`
`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_____________________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`_____________________________
`
`
`MODERNA THERAPEUTICS, INC.,
`Petitioner,
`
`v.
`
`PROTIVA BIOTHERAPEUTICS, INC.,
`Patent Owner.
`_____________________________
`
`Case IPR2018-00739
`Patent No. 9,364,435
`_____________________________
`
`
`PATENT OWNER PROTIVA BIOTHERAPEUTICS, INC.’S
`POWER OF ATTORNEY
`
`
`
`
`
`Pursuant to 37 C.F.R. § 42.10(b), Patent Owner Protiva Biotherapeutics, Inc.
`
`hereby appoints the following practitioners as its attorneys to transact all business
`
`in the United States Patent & Trademark Office associated with a petition for inter
`
`partes review of U.S. Patent No. 9,364,435:
`
`Back-Up Counsel
`Edward R. Reines
`Pro hac vice pending
`Weil, Gotshal & Manges LLP
`201 Redwood Shores Parkway
`Redwood Shores, CA 94065
`Tel.: 650-802-3022
`Email: Edward.reines@weil.com
`
`Back-Up Counsel
`Derek C. Walter
`USPTO Reg. No. 74,656
`Weil, Gotshal & Manges LLP
`201 Redwood Shores Parkway
`Redwood Shores, CA 94065
`Tel.: 650-802-3934
`Email: derek.walter@weil.com
`
`
`
`
`By: ______________________________
`For: Patent Owner Protiva Biotherapeutics, Inc.
`Name: Mark Murray
`Title: President and CEO of Arbutus Biopharma
`Corporation
`Date: ____________________________
`
`
`
`-1-
`
`May 30, 2018
`
`